Lupus (SLE): vizsgálatok itt: Kína
163 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleThe BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases
- Where
- Nanjing
- Életkor
- 18 év to 65 év
- People
- 24
- Run by
- Nanjing University School of Medicine
See details and how to joinNCT06285279 - No phaseCsak meghívásosStudy on Early Visual Dysfunction in Patients With Systemic Lupus Erythematosus
- Where
- Hefei
- People
- 100
- Run by
- The First Affiliated Hospital of Anhui Medical University
See details and how to joinNCT07679776 - Korai 1. fázisTaking peopleMTS109 in Patients With Refractory Autoimmune Diseases
- Where
- Shanghai
- Életkor
- 18 év to 65 év
- People
- 15
- Run by
- Shanghai Changzheng Hospital
See details and how to joinNCT07526350 - 1. fázisNot yet taking people in KínaA Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
- Where
- Qingdao
- Életkor
- 18 év to 70 év
- People
- 18
- Run by
- The Affiliated Hospital of Qingdao University
See details and how to joinNCT07676266 - 1/2. fázisTaking peopleA Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 218
- Run by
- ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
See details and how to joinNCT06535412 - Korai 1. fázisTaking peopleUniversal Anti-CD70 CAR-T (CHT101) Cell Therapy for Relapsed Refractory Systemic Lupus Erythematosus
- Where
- Nanjing
- Életkor
- 18 év to 65 év
- People
- 15
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06946485 - Korai 1. fázisNot yet taking people in KínaRD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases
- Where
- Hangzhou, Nanjing
- Életkor
- 5 év to 20 év
- People
- 30
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07674147 - No phaseCsak meghívásosCHT105 for the Treatment of Refractory Lupus Nephritis
- Where
- Nanjing
- Életkor
- 18 év to 65 év
- People
- 14
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07517536 - 2/3. fázisTaking peopleSirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia
- Where
- Beijing
- Életkor
- 18 év to 65 év
- People
- 164
- Run by
- Chinese SLE Treatment And Research Group
See details and how to joinNCT07657793 - 1. fázisTaking peopleNK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis
- Where
- Guangzhou
- Életkor
- 18 év to 65 év
- People
- 18
- Run by
- Guangdong Provincial People's Hospital
See details and how to joinNCT06676631 - Korai 1. fázisTaking peopleEvaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B Cell-Mediated Autoimmune Diseases (SLE and AIHA)
- Where
- Beijing
- Életkor
- 18 év to 60 év
- People
- 5
- Run by
- Circunited BioPharma (Shenzhen) Co., Ltd.
See details and how to joinNCT07629596 - Korai 1. fázisTaking peopleDual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 18
- Run by
- RenJi Hospital
See details and how to joinNCT05858684 - Korai 1. fázisTaking peopleIASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 18
- Run by
- Peking University People's Hospital
See details and how to joinNCT07617740 - No phaseNot yet taking people in KínaA Study to Evaluate MTM-H-001 Injection in Adult Patients With B-Cell-Related Autoimmune Diseases
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 75
- Run by
- Beijing GoBroad Hospital
See details and how to joinNCT07593911 - 3. fázisTaking peopleA Phase 3 Clinical Study of MIL62 in Systemic Lupus Erythematosus
- Where
- Beijing
- Életkor
- 18 év to 80 év
- People
- 316
- Run by
- Beijing Mabworks Biotech Co., Ltd.
See details and how to joinNCT07405970 - No phaseTaking peopleExploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases
- Where
- Nanjing
- Életkor
- 18 év to 70 év
- People
- 72
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07558850 - No phaseTaking peopleEarly Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus
- Where
- Shanghai
- Életkor
- 7 év to 17 év
- People
- 60
- Run by
- Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT07425730 - 2. fázisTaking peopleA Study of D-2570 in Patients With Active Systemic Lupus Erythematosus (SLE)
- Where
- Linfen
- Életkor
- 18 év to 70 év
- People
- 120
- Run by
- InventisBio Co., Ltd
See details and how to joinNCT07311200 - Korai 1. fázisNot yet taking people in KínaEfficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy
- Where
- Xi'an
- Életkor
- 18 év to 65 év
- People
- 15
- Run by
- Air Force Military Medical University, China
See details and how to joinNCT07535138 - Korai 1. fázisTaking peopleA Study of CC312 for Relapsed/Refractory Autoimmune Diseases
- Where
- Deyang
- Életkor
- 18 év to 65 év
- People
- 6
- Run by
- CytoCares Inc
See details and how to joinNCT07193810 - 1/2. fázisTaking peopleSELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus
- Where
- Shenzhen
- Életkor
- 18 év to 70 év
- People
- 24
- Run by
- Beijing Biotech
See details and how to joinNCT07523542 - 1. fázisNot yet taking people in KínaStudy of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 30
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07512947 - Korai 1. fázisTaking peopleExploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases
- Where
- Hangzhou
- Életkor
- 5 év and over
- People
- 36
- Run by
- The Children's Hospital of Zhejiang University School of Medicine
See details and how to joinNCT07490041 - No phaseTaking peopleClinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
- Where
- Wuhan
- Életkor
- 18 év to 70 év
- People
- 12
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07470151 - 2. fázisTaking peopleThe Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment
- Where
- Nanjing
- Életkor
- 14 év to 65 év
- People
- 50
- Run by
- Nanjing University School of Medicine
See details and how to joinNCT07340463